Introduction: The negative efficacy results of coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) as early treatment in the COnV-ert trial have been attributed to the use of methylene blue ...
(MENAFN- GlobeNewsWire - Nasdaq) The market opportunity lies in offering a specialized course for clinical research professionals to enhance their project management skills, both technical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback